- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to compare the severity of ISR related pain following degarelix s.c. administrations with two different injection techniques and i.m. administration in prostate cancer patients during the 7-month trial period.
Critère d'inclusion
- FIRMAGON is indicated for treatment of adult male patients with advanced hormone-dependent prostate cancer